. . . . . . . . . . . . "a(SCHEM:Biliverdine) -| r(RGD:Icam1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Biliverdin significantly improved survival of recipients following SITx after prolonged intestinal ischemia (6 hours). Biliverdin treatment (1) led to a significant decrease in mRNA expression of iNOS, Cox-2, and ICAM-1 as well as the inflammatory cytokines IL-6 and IL-1beta" . . "Selventa" . . . . "2014-07-03T14:32:26.879+02:00"^^ . . .